# Clinical Assessment of a HYDRAGLYDE® Regimen

> **NCT03026257** · NA · COMPLETED · sponsor: **Alcon, a Novartis Company** · enrollment: 323 (actual)

## Conditions studied

- Refractive Errors
- Myopia
- Hypermetropia

## Interventions

- **DEVICE:** Lotrafilcon B contact lenses with added wetting agent
- **DEVICE:** Samfilcon A contact lenses
- **DEVICE:** POLYQUAD/ALDOX-preserved contact lens solution with added wetting agent
- **DEVICE:** Hydrogen peroxide-based contact lens solution with added wetting agent
- **DEVICE:** Senofilcon C contact lenses
- **DEVICE:** Senofilcon A contact lenses
- **DEVICE:** Comfilcon A contact lenses
- **DEVICE:** Habitual Multi-Purpose Solution (HMPS)

## Key facts

- **NCT ID:** NCT03026257
- **Lead sponsor:** Alcon, a Novartis Company
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-13
- **Primary completion:** 2017-08-18
- **Final completion:** 2017-08-18
- **Target enrollment:** 323 (ACTUAL)
- **Last updated:** 2018-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03026257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03026257, "Clinical Assessment of a HYDRAGLYDE® Regimen". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03026257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*